Driving Commercial Success for Precision Medicine: Understand the Market to Maximize Patient Identification and Therapy Adoption

Life Sciences, Pharmaceutical, Drug Discovery & Development, Commercialization & HEOR,
  • Thursday, September 05, 2024

Webinar Preview

Bringing precision medicines and targeted therapies to market involves unique requirements beyond those of traditional therapies. One key aspect is identifying the specific patient sub-population where the therapy has demonstrated efficacy, which is achieved through biomarker and diagnostic testing.

Consequently, drug developers must not only consider the development and commercialization of the therapeutic asset but also the development and commercialization of a biomarker or diagnostic test to maximize patient identification. The first step to success is understanding the market landscape.

The Diaceutics 6A™ Commercial Framework combines industry-leading expertise with unique data capabilities to provide a comprehensive understanding of the market landscape. This framework can help identify opportunities and leverage points to inform development choices and commercial strategies for pharmaceutical and biotech drug developers, enabling global commercial success for precision medicines.

Read more...

In this webinar, the expert speaker will focus on optimizing therapy adoption within the precision medicine landscape. They will delve into key market trends and strategies that are critical for achieving commercial success. By dissecting the unique patient journey and understanding the broader market dynamics, attendees will be provided with actionable insights that can be directly applied to market strategies.

Additionally, the webinar will explore strategic positioning using real-world data to effectively position therapies in competitive markets. The speaker will also cover cost-efficient approaches to launching precision medicines and discuss the essential elements of a streamlined commercialization strategy.

Read Less...

Register for this webinar today to understand how to optimize therapy adoption, leverage real-world data for strategic positioning and implement cost-efficient approaches to launch precision medicine.

Keywords:
Register

Speaker

Kevin Entwistle, Diaceutics

Kevin Entwistle, VP of Scientific & Advisory Services, Diaceutics

Kevin Entwistle has over 15 years of experience working in the pharmaceutical industry and supporting global leaders to develop impactful commercialization strategies for the launch of precision medicines. He has previously worked for Qiagen, Leica Biosystems and J&J. Kevin’s expertise extends across multiple indications including oncology, neurology, immunology, cardiovascular and rare diseases.

As VP of Scientific & Advisory Services at Diaceutics PLC, Kevin utilizes his extensive experience and Diaceutics’ real-world data to provide pharmaceutical and biotech customers with a deep understanding of the current precision medicine landscape and the strategic guidance required to successfully launch therapies to market, enhancing patient outcomes and driving the adoption of precision medicines.

Message Presenter

Message Presenter

Have questions or would like more information? Use the form below to send a message.

Who Should Attend?

This webinar will appeal to Executives in the following fields or those involved in the planning of a precision medicine launch:

  • Global commercial operations
  • Marketing and commercial strategy/operations
  • Precision medicine portfolio planning/marketing/diagnostics
  • Market access
  • Medical affairs

What You Will Learn

Attendees will learn about: 

  • How to evaluate the market landscape for commercialization opportunities and optimize therapy adoption for your indication
  • How to effectively structure your commercial plans for optimum success utilising Diaceutics’ 6A™ planning framework
  • How RWD can provide the insight required to assess market testing dynamics to position therapies effectively against competitors
  • How the reimbursement landscape can impact test adoption and availability and the tactics to support seamless testing
  • Why assessing biomarker testing awareness will support greater identification of eligible patients

Xtalks Partner

Diaceutics_Logo

Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.

DXRX is the world’s first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform-enabled solutions.

Related Webinars

November 13, 2024

Cutting Through the Noise: Data-Driven Physician Engagement in Precision Medicine
October 10, 2024

Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine
Diaceutics_Oct10_HeroImage

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account